Having trouble accessing articles? Reset your cache.

Tarextumab: Updated Phase Ib/II data

Updated data from 27 patients with SCLC in the dose-escalation Phase Ib portion of the international Phase Ib/II PINNACLE trial showed that

Read the full 226 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE